Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-196

Buy the rumor, sell the news.

It really is easy for big instos to mop up shares, isn't it, as this morning evidences. You can bet this is shares transferring from ignorant punters to the Big End of Town. It astonishes me that anyone would sell based on yesterday's news that two of the biggest pharmas on the planet have agreed to provide free drugs for trials they do not control (Imugene has designed and will run the trials). Who does not understand the gravitas of that announcement? Oh yes, those who bailed out this morning at the first sign that investors were 'exiting in panic'.

Silly me: I bought more at 57. Should have just waited five minutes and would have got them at 55.

Mind you, that two cents will pale into insignificance as news unfolds across multiple trials in coming months.

Please folks, don't give them your shares.

OOO